Literature DB >> 7686693

A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV deficiency.

H Kashiwagi1, S Honda, Y Tomiyama, H Mizutani, H Take, Y Honda, S Kosugi, Y Kanayama, Y Kurata, Y Matsuzawa.   

Abstract

To clarify the molecular basis of the deficiency of glycoprotein IV (GPIV) of the platelet surface, we analyzed GPIV cDNA synthesized from platelet RNA of five unrelated Japanese subjects whose platelets did not express GPIV. We confirmed the presence of normal-sized GPIV mRNA in platelets from subjects with GPIV deficiency. The sequence of platelet GPIV cDNA from GPIV deficient subject showed three differences when compared with the published sequence; 1) a replacement of a 478CCT codon for proline-90 by TCT for serine, 2) a four-base insertion in the 3'-noncoding region, and 3) a substitution of A for 79C in the 5'-noncoding region. The replacement of Pro90 by Ser predominates in subjects with GPIV deficiency; that is, four out of five platelets with GPIV deficiency contained GPIV mRNA encoding GPIVSer-90, while all platelets from 17 GPIV positive subjects had GPIV mRNA encoding GPIVPro-90. The sequence of platelet GPIV cDNA which did not encode GPIVSer-90 from a subject with GPIV deficiency revealed no abnormality in the coding region. The four-base insertion in the 3'-noncoding region and the substitution of A for 79C in the 5'-noncoding region seems to be unrelated to the expression of GPIV. The substitution of Ser for Pro90 might alter the GPIV structure or impair GPIV biosynthesis, resulting in a lack of detectable GPIV. This hypothesis remains to be tested.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686693

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Molecular basis of human CD36 gene mutations.

Authors:  Monika Ewa Rać; Krzysztof Safranow; Wojciech Poncyljusz
Journal:  Mol Med       Date:  2007 May-Jun       Impact factor: 6.354

Review 2.  Role of carotenoids and retinoids during heart development.

Authors:  Ioan Ovidiu Sirbu; Aimée Rodica Chiş; Alexander Radu Moise
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2020-01-22       Impact factor: 4.698

3.  Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects.

Authors:  S Nozaki; H Kashiwagi; S Yamashita; T Nakagawa; B Kostner; Y Tomiyama; A Nakata; M Ishigami; J Miyagawa; K Kameda-Takemura
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

4.  CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency.

Authors:  S Nozaki; T Tanaka; S Yamashita; K Sohmiya; T Yoshizumi; F Okamoto; Y Kitaura; C Kotake; H Nishida; A Nakata; T Nakagawa; K Matsumoto; K Kameda-Takemura; S Tadokoro; Y Kurata; Y Tomiyama; K Kawamura; Y Matsuzawa
Journal:  Mol Cell Biochem       Date:  1999-02       Impact factor: 3.396

5.  Variants of CD36 gene and their association with CD36 protein expression in platelets.

Authors:  Xianguo Xu; Ying Liu; Xiaozhen Hong; Shu Chen; Kairong Ma; Xiaofei Lan; Yanling Ying; Ji He; Faming Zhu; Hangjun Lv
Journal:  Blood Transfus       Date:  2014-06-12       Impact factor: 3.443

6.  Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction.

Authors:  Joshua W Knowles; Huijan Wang; Haruka Itakura; Audrey Southwick; Richard M Myers; Carlos Iribarren; Stephen P Fortmann; Alan S Go; Thomas Quertermous; Mark A Hlatky
Journal:  Am Heart J       Date:  2007-12       Impact factor: 4.749

7.  Molecular basis of CD36 deficiency. Evidence that a 478C-->T substitution (proline90-->serine) in CD36 cDNA accounts for CD36 deficiency.

Authors:  H Kashiwagi; Y Tomiyama; S Honda; S Kosugi; M Shiraga; N Nagao; S Sekiguchi; Y Kanayama; Y Kurata; Y Matsuzawa
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

8.  Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients.

Authors:  Shizuya Yamashita; Ken-ichi Hirano; Takahiro Kuwasako; Mohamed Janabi; Yumiko Toyama; Masato Ishigami; Naohiko Sakai
Journal:  Mol Cell Biochem       Date:  2007-05       Impact factor: 3.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.